Copyright Reports & Markets. All rights reserved.

Global Skin Cancer Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Skin Cancer Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Basal Cell Carcinoma
      • 1.4.3 Squamous Cell Carcinoma
      • 1.4.4 Malignant Melanoma
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Skin Cancer Diagnostics Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Laboratory
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Skin Cancer Diagnostics Market Size
    • 2.2 Skin Cancer Diagnostics Growth Trends by Regions
      • 2.2.1 Skin Cancer Diagnostics Market Size by Regions (2014-2025)
      • 2.2.2 Skin Cancer Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Skin Cancer Diagnostics Market Size by Manufacturers
      • 3.1.1 Global Skin Cancer Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Skin Cancer Diagnostics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Skin Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Skin Cancer Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Skin Cancer Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Skin Cancer Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Skin Cancer Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Skin Cancer Diagnostics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Skin Cancer Diagnostics Market Size (2014-2019)
    • 5.2 Skin Cancer Diagnostics Key Players in United States
    • 5.3 United States Skin Cancer Diagnostics Market Size by Type
    • 5.4 United States Skin Cancer Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Skin Cancer Diagnostics Market Size (2014-2019)
    • 6.2 Skin Cancer Diagnostics Key Players in Europe
    • 6.3 Europe Skin Cancer Diagnostics Market Size by Type
    • 6.4 Europe Skin Cancer Diagnostics Market Size by Application

    7 China

    • 7.1 China Skin Cancer Diagnostics Market Size (2014-2019)
    • 7.2 Skin Cancer Diagnostics Key Players in China
    • 7.3 China Skin Cancer Diagnostics Market Size by Type
    • 7.4 China Skin Cancer Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Skin Cancer Diagnostics Market Size (2014-2019)
    • 8.2 Skin Cancer Diagnostics Key Players in Japan
    • 8.3 Japan Skin Cancer Diagnostics Market Size by Type
    • 8.4 Japan Skin Cancer Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Skin Cancer Diagnostics Market Size (2014-2019)
    • 9.2 Skin Cancer Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Skin Cancer Diagnostics Market Size by Type
    • 9.4 Southeast Asia Skin Cancer Diagnostics Market Size by Application

    10 India

    • 10.1 India Skin Cancer Diagnostics Market Size (2014-2019)
    • 10.2 Skin Cancer Diagnostics Key Players in India
    • 10.3 India Skin Cancer Diagnostics Market Size by Type
    • 10.4 India Skin Cancer Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Skin Cancer Diagnostics Market Size (2014-2019)
    • 11.2 Skin Cancer Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Skin Cancer Diagnostics Market Size by Type
    • 11.4 Central & South America Skin Cancer Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Alma Lasers
      • 12.1.1 Alma Lasers Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Skin Cancer Diagnostics Introduction
      • 12.1.4 Alma Lasers Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.1.5 Alma Lasers Recent Development
    • 12.2 Agilent Technologies Inc
      • 12.2.1 Agilent Technologies Inc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Skin Cancer Diagnostics Introduction
      • 12.2.4 Agilent Technologies Inc Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.2.5 Agilent Technologies Inc Recent Development
    • 12.3 Biolitec Ag
      • 12.3.1 Biolitec Ag Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Skin Cancer Diagnostics Introduction
      • 12.3.4 Biolitec Ag Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.3.5 Biolitec Ag Recent Development
    • 12.4 Bruker Corp
      • 12.4.1 Bruker Corp Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Skin Cancer Diagnostics Introduction
      • 12.4.4 Bruker Corp Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.4.5 Bruker Corp Recent Development
    • 12.5 Ellipse A/S
      • 12.5.1 Ellipse A/S Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Skin Cancer Diagnostics Introduction
      • 12.5.4 Ellipse A/S Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.5.5 Ellipse A/S Recent Development
    • 12.6 GE Healthcare
      • 12.6.1 GE Healthcare Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Skin Cancer Diagnostics Introduction
      • 12.6.4 GE Healthcare Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.6.5 GE Healthcare Recent Development
    • 12.7 Leica Microsystems
      • 12.7.1 Leica Microsystems Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Skin Cancer Diagnostics Introduction
      • 12.7.4 Leica Microsystems Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.7.5 Leica Microsystems Recent Development
    • 12.8 Michelson Diagnostics
      • 12.8.1 Michelson Diagnostics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Skin Cancer Diagnostics Introduction
      • 12.8.4 Michelson Diagnostics Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.8.5 Michelson Diagnostics Recent Development
    • 12.9 Syneron Medical
      • 12.9.1 Syneron Medical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Skin Cancer Diagnostics Introduction
      • 12.9.4 Syneron Medical Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.9.5 Syneron Medical Recent Development
    • 12.10 Toshiba Medical Systems
      • 12.10.1 Toshiba Medical Systems Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Skin Cancer Diagnostics Introduction
      • 12.10.4 Toshiba Medical Systems Revenue in Skin Cancer Diagnostics Business (2014-2019)
      • 12.10.5 Toshiba Medical Systems Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Skin cancer is diagnosed by physical examination and biopsy. Biopsy is a quick and simple procedure where part or all of the spot is removed and sent to a laboratory.
      Major market drivers are Increasing incidence of melanoma and non-melanoma skin cancer, Technological advancements, Imaging techniques offers the confirmatory diagnostic tests and Product differentiation to drive growth and prevent threat of substitutes are the major market drivers.
      In 2018, the global Skin Cancer Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Skin Cancer Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Skin Cancer Diagnostics development in United States, Europe and China.

      The key players covered in this study
      Alma Lasers
      Agilent Technologies Inc
      Biolitec Ag
      Bruker Corp
      Ellipse A/S
      GE Healthcare
      Leica Microsystems
      Michelson Diagnostics
      Syneron Medical
      Toshiba Medical Systems

      Market segment by Type, the product can be split into
      Basal Cell Carcinoma
      Squamous Cell Carcinoma
      Malignant Melanoma
      Others

      Market segment by Application, split into
      Hospital
      Clinic
      Laboratory
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Skin Cancer Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Skin Cancer Diagnostics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Skin Cancer Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now